EC Healthcare has released its annual report and business review for the year ending March 31, 2024. During this year, the company achieved revenue of HKD 4211.034 million. EC Healthcare's business spans Hong Kong, Macau, and mainland China. The company's dividend policy entails that final dividends must be approved by shareholders before being confirmed as liabilities, while interim dividends are confirmed upon proposal and announcement. Additionally, the company operates stock option and stock reward plans, and includes the share-based payment expense in employee costs. Shareholder rights include final dividends requiring shareholder approval and interim dividends being declared by the board of directors. Major risks and uncertainties include impairment of goodwill and non-financial assets, as well as uncertainty in estimating...Show More

EC Healthcare has released its annual report and business review for the year ending March 31, 2024. During this year, the company achieved revenue of HKD 4211.034 million. EC Healthcare's business spans Hong Kong, Macau, and mainland China. The company's dividend policy entails that final dividends must be approved by shareholders before being confirmed as liabilities, while interim dividends are confirmed upon proposal and announcement. Additionally, the company operates stock option and stock reward plans, and includes the share-based payment expense in employee costs. Shareholder rights include final dividends requiring shareholder approval and interim dividends being declared by the board of directors. Major risks and uncertainties include impairment of goodwill and non-financial assets, as well as uncertainty in estimating deferred tax assets. Director changes include resignations and reappointments, and detailed information is provided in the text. The operating segment includes medical services, cosmetic medical and health beauty services, and veterinary and other services. Geographic information shows that revenue and specific non-current assets are located in Hong Kong, Macau, and mainland China. There is no disclosure of major customer information as no single customer represents over 10% of total revenue.